1. The metalloprotease-directed shedding of BP 180 (collagen XVII) from human keratinocytes in culture is unaffected by ceramide and cell-matrix interaction.
- Author
-
Labrousse AL, Buisson-Legendre N, Hornebeck W, and Bernard P
- Subjects
- Adult, Aged, Autoantigens, Cell Communication, Cell Membrane physiology, Cells, Cultured, Ceramides metabolism, Dystonin, Humans, Matrix Metalloproteinases metabolism, Middle Aged, Phenylalanine pharmacology, Thiophenes pharmacology, Collagen Type XVII, Carrier Proteins, Collagen metabolism, Cytoskeletal Proteins, Keratinocytes immunology, Metalloendopeptidases physiology, Nerve Tissue Proteins, Non-Fibrillar Collagens, Phenylalanine analogs & derivatives
- Abstract
The constitutive shedding of BP180 (collagen XVII) from human keratinocytes in culture was totally prevented by batimastat (5 microM), a wide spectrum matrix metalloprotease (MMP) inhibitor. However, keratinocytes did not express active MMP and generation of active Gelatinase A (MMP-2) and Gelatinase B (MMP-9) at the cell plasma membrane by increasing the ceramide content of keratinocytes did not influence BP180 processing to a 120 kDa species. A disintegrin and metalloprotease (ADAM) is probably involved in such a shedding event since release of 120 kDa polypeptide was inhibited by Decanoyl-Arg-Val-Lys-Arg CH2Cl (30 microM), a specific furin convertase inhibitor; culturing cells on to several matrix substrata i.e. type I collagen, type IV collagen, laminin-1 or laminin-5 had no effect on BP180 processing. Overall our data indicated that the metalloprotease-mediated shedding of BP180 from keratinocytes in culture is insensitive either to agents which activate MAP kinase pathway (ceramide) or to cell-matrix interactions.
- Published
- 2002